Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures: a Randomized, Active Comparator-controlled, Blinded Trial

NCT02679560 is registered in ClinicalTrials.gov with Ian Elliott Brown as lead sponsor.

NCT NCT02679560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02679560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures: a Randomized, Active Comparator-controlled, Blinded Trial
Lead sponsor
Ian Elliott Brown
Phase
Phase 2
Overall status
Terminated
Start date
October 1, 2017
Completion date
November 1, 2019
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

femoral fractures